glucose, (beta-d)-isomer has been researched along with Granulomatous Disease, Chronic in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (80.49) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 2 (4.88) | 29.6817 |
| 2010's | 1 (2.44) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bagaitkar, J; Bhattacharya, S; Dinauer, MC; Greenberg, ZJ; Huang, G; Schuettpelz, LG; Song, Z; Yang, W | 1 |
| Aratani, Y; Endo, D; Sugimoto, Y | 1 |
| Bratton, DL; Fernandez-Boyanapalli, R; Frasch, SC; Henson, PM; Riches, DW; Vandivier, RW | 1 |
| Német, K; Selmeczy, Z; Szelényi, J; Vizi, ES | 1 |
| Borinsky, R; Falkenberg, S; Gillert, KE; Ginsburg, I; Lahav, M; Muller, S; Winkler, M | 1 |
| Chovaniec, ME; Cohen, HJ; Kruskall, MS; Newburger, PE; Rappeport, JM; Robinson, SH | 1 |
| Chovaniec, ME; Cohen, HJ; Newburger, PE; Simons, ER; Whitin, JC | 1 |
| Clark, RA; Szot, S | 1 |
| Johnston, RB; McPhail, LC; Musson, RA; Shafran, H | 1 |
| Bellavite, P; Della Bianca, V; Dri, P; Serra, MC | 1 |
| Donowitz, GR; Kay, HD; Mandell, GL; Smith, DL; Sullivan, G | 1 |
| Banchi, L; Dallegri, F; Frumento, G; Patrone, F; Sacchetti, C | 1 |
| Elkjaer, D; Strate, M; Wang, P | 1 |
| Fertel, RH; Kraut, EH; Sagone, AL; Segal, ML | 1 |
| Ballestrero, A; Dallegri, F; Frumento, G; Maggi, AM; Muttini, P; Patrone, F | 1 |
| Kraut, EH; Sagone, AL; Segal, M | 1 |
| Andrews, PC; Babior, BM | 1 |
| Penny, R; Robinson, JP | 1 |
| Baehner, RL; Boxer, LA; Haak, RA; Ingraham, LM | 1 |
| DeChatelet, LR; Shirley, PS | 1 |
| Loos, JA; Roos, D; Voetman, AA | 1 |
| King, JW; McCall, CE | 1 |
| Mills, EL; Quie, PG; Rholl, KS | 1 |
| Nakamura, M; Nakamura, MA; Yanai, M | 1 |
| Gahr, M; Heyden, S; Jendrossek, V; Neubauer, B; Ritzel, A | 1 |
| De Boer, M; Hack, WW; Kuijpers, TW; Neefjes, VM; Roos, D; Weening, RS | 1 |
| Clark, RA; Klebanoff, SJ | 1 |
| Klebanoff, SJ; Rosen, H | 1 |
| Babior, BM; Curnutte, JT; Kipnes, RS | 1 |
| Fiegel, VD; Herron, M; McCormack, RT; Nelson, RD; Quie, PG; Simmons, RL | 1 |
| Biggar, WD; Issekutz, AC; Lee, KY | 1 |
| Biggar, WD; Buron, S; Holmes, B | 1 |
| Babior, BM; Kipnes, RS | 1 |
| Reasor, MJ; Trush, MA; Van Dyke, K; Wilson, ME | 1 |
| Barsukov, AA; Gomes, LA; Iartsev, MN; Prisiazhniuk, VA | 1 |
| Emmendörffer, A; Hecht, M; Lohmann-Matthes, ML; Roesler, J | 1 |
| Glette, J; Halstensen, A; Haneberg, B; Sandberg, S; Solberg, CO | 1 |
| Brown, EJ; Gresham, HD; McGarr, JA; Shackelford, PG | 1 |
| Roos, D; van Schaik, ML; Verhoeven, AJ; Weening, RS | 1 |
| Kramer, IM; Roos, D; van der Bend, RL; Verhoeven, AJ; Weening, RS | 1 |
| Peerless, AG; Stiehm, ER | 1 |
41 other study(ies) available for glucose, (beta-d)-isomer and Granulomatous Disease, Chronic
| Article | Year |
|---|---|
NADPH oxidase 2 limits amplification of IL-1β-G-CSF axis and an immature neutrophil subset in murine lung inflammation.
Topics: Animals; Granulocyte Colony-Stimulating Factor; Granulomatous Disease, Chronic; Inflammation; Interleukin-1beta; Leukotriene B4; Mice; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Pneumonia; Zymosan | 2023 |
Mice Deficient in NOX2 Display Severe Thymic Atrophy, Lymphopenia, and Reduced Lymphopoiesis in a Zymosan-Induced Model of Systemic Inflammation.
Topics: Animals; Atrophy; Disease Models, Animal; Dose-Response Relationship, Drug; Granulomatous Disease, Chronic; Lymphopenia; Lymphopoiesis; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; Systemic Inflammatory Response Syndrome; Thymus Gland; Zymosan | 2021 |
PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.
Topics: Animals; Cytokines; Gene Deletion; Gene Expression Regulation; Granulomatous Disease, Chronic; Humans; Inflammation; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Peritonitis; Pioglitazone; PPAR gamma; Thiazolidinediones; Zymosan | 2010 |
The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells.
Topics: Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Granulocytes; Granulomatous Disease, Chronic; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophages; Monocytes; Mutation; N-Formylmethionine Leucyl-Phenylalanine; Receptors, Cell Surface; Receptors, Complement 3b; Receptors, IgG; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 2003 |
Bacteria and zymosan opsonized with histone, dextran sulfate, and polyanetholesulfonate trigger intense chemiluminescence in human blood leukocytes and platelets and in mouse macrophages: modulation by metabolic inhibitors in relation to leukocyte-bacteri
Topics: Adult; Animals; Bacteria; Blood Platelets; Child; Child, Preschool; Dextran Sulfate; Dextrans; Granulomatous Disease, Chronic; Histones; Humans; Leukocytes; Ligands; Luminescent Measurements; Macrophages; Mice; Mice, Inbred Strains; Opsonin Proteins; Phagocytosis; Polyanetholesulfonate; Staphylococcal Infections; Streptococcal Infections; Zymosan | 1982 |
Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
Topics: Adolescent; Adult; Blood Bactericidal Activity; Bone Marrow Cells; Cells, Cultured; Female; Granulomatous Disease, Chronic; Hematopoietic Stem Cells; Humans; Male; Nitroblue Tetrazolium; Opsonin Proteins; Oxidation-Reduction; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1980 |
Opsonized zymosan-stimulated granulocytes-activation and activity of the superoxide-generating system and membrane potential changes.
Topics: Animals; Benzothiazoles; Calcium; Carbocyanines; Cyanides; Cytochrome c Group; Deoxyglucose; Ethylmaleimide; Granulocytes; Granulomatous Disease, Chronic; Guinea Pigs; Humans; Membrane Potentials; Neutrophils; Opsonin Proteins; Oxygen; Superoxides; Temperature; Zymosan | 1981 |
Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
Topics: Aminopeptidases; Candidiasis; Catalysis; Chemotactic Factors; Complement C5; Complement C5a; Granulomatous Disease, Chronic; Humans; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Peroxidase; Peroxidases; Sulfides; Tetradecanoylphorbol Acetate; Zymosan | 1982 |
Differences in the ability of human peripheral blood monocytes and in vitro monocyte-derived macrophages to produce superoxide anion: studies with cells from normals and patients with chronic granulomatous disease.
Topics: Adult; Calcimycin; Cells, Cultured; Female; Granulomatous Disease, Chronic; Humans; Infant; Macrophages; Male; Monocytes; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Opsonin Proteins; Oxygen; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1982 |
The measurement of superoxide anion production by granulocytes In whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity.
Topics: Female; Granulocytes; Granulomatous Disease, Chronic; Humans; Male; Opsonin Proteins; Phagocytosis; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1983 |
Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
Topics: Cell Differentiation; Cytochrome c Group; Cytotoxicity, Immunologic; Granulomatous Disease, Chronic; Humans; Killer Cells, Natural; Luminescent Measurements; Monocytes; Neutrophils; Nitroblue Tetrazolium; Tetradecanoylphorbol Acetate; Zymosan | 1983 |
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells.
Topics: Animals; Catalase; Cattle; Chickens; Erythrocytes; Granulomatous Disease, Chronic; Humans; Neutrophils; Opsonin Proteins; Phagocytosis; Superoxide Dismutase; Zymosan | 1984 |
A radiometric whole blood test for chronic granulomatous disease.
Topics: Carbon Dioxide; Granulocytes; Granulomatous Disease, Chronic; Humans; Indicators and Reagents; Radiometry; Zymosan | 1984 |
The role of reactive oxygen species in thromboxane b2 generation by polymorphonuclear leukocytes.
Topics: Catalase; Free Radicals; Granulomatous Disease, Chronic; Humans; Neutrophils; Oxygen; Phospholipases A; Phospholipases A2; Prostaglandins F; Superoxide Dismutase; Thromboxane B2; Thromboxanes; Zymosan | 1983 |
Neutrophil-mediated cellular cytotoxicity induced by zymosan-activated serum.
Topics: Azides; Blood Physiological Phenomena; Catalase; Child; Cytotoxicity, Immunologic; Granulomatous Disease, Chronic; Hemolysis; Humans; Male; Neutrophils; Potassium Cyanide; Sodium Azide; Superoxide Dismutase; Zymosan | 1984 |
Evaluation of the role of oxygen radicals in polymorphonuclear leukocyte aggregation.
Topics: Benzoates; Benzoic Acid; Catalase; Cell Aggregation; Chemotaxis, Leukocyte; Free Radicals; Granulomatous Disease, Chronic; Humans; Hydrocortisone; Mannitol; Neutrophils; Oxygen; Superoxide Dismutase; Zymosan | 1982 |
Endogenous protein phosphorylation by resting and activated human neutrophils.
Topics: Digitonin; Granulomatous Disease, Chronic; Humans; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phosphoproteins; Phosphorylation; Tetradecanoylphorbol Acetate; Zymosan | 1983 |
Chemiluminescence response in normal human phagocytes. I. Automated measurements using a standard liquid scintillation counter.
Topics: Computers; Granulomatous Disease, Chronic; Humans; Luminescent Measurements; Monocytes; Neutrophils; Phagocytes; Scintillation Counting; Zymosan | 1982 |
Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes.
Topics: Granulomatous Disease, Chronic; Humans; Membrane Fluidity; Neutrophils; Phagocytosis; Superoxide Dismutase; Zymosan | 1981 |
Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood.
Topics: Child; Granulomatous Disease, Chronic; Humans; Luminescent Measurements; Luminol; Microchemistry; Neutrophils; Oxygen Consumption; Tetradecanoylphorbol Acetate; Zymosan | 1981 |
Changes in the levels of glutathione in phagocytosing human neutrophils.
Topics: Cell Separation; Dithionitrobenzoic Acid; Formaldehyde; Glucose; Glucose Oxidase; Glutathione; Granulomatous Disease, Chronic; Humans; Neutrophils; Phagocytosis; Zymosan | 1980 |
Simplified neutrophil hexose monophosphate shunt assay on whole blood.
Topics: Adult; Blood Bactericidal Activity; Erythrocytes; Granulomatous Disease, Chronic; Hexosephosphates; Humans; Infant, Newborn; Leukocytes; Neutrophils; Phagocytosis; Zymosan | 1980 |
Luminol-amplified chemiluminescence: a sensitive method for detecting the carrier state in chronic granulomatous disease.
Topics: Adult; Blood Bactericidal Activity; Child; Female; Genetic Carrier Screening; Granulomatous Disease, Chronic; Humans; Luminescent Measurements; Luminol; Male; Neutrophils; Phagocytosis; Pyridazines; Staphylococcus aureus; Zymosan | 1980 |
Polarographic micromethods for the rapid assay of phagocytosis-connected oxygen consumption by leukocytes in diluted peripheral blood.
Topics: Granulomatous Disease, Chronic; Humans; Leukocytes; Microchemistry; Opsonin Proteins; Oxygen Consumption; Phagocytosis; Polarography; Zymosan | 1981 |
An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
Topics: Adult; Amino Acid Sequence; Antibodies; Bacterial Infections; Cytochrome b Group; Exons; Fatal Outcome; Female; Genetic Carrier Screening; Granulocytes; Granulomatous Disease, Chronic; Heme; Humans; Male; Membrane Glycoproteins; Models, Structural; Molecular Sequence Data; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Pedigree; Peptide Fragments; Polymorphism, Genetic; Protein Conformation; Sequence Deletion; Superoxides; Tetradecanoylphorbol Acetate; X Chromosome; Zymosan | 1997 |
Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
Topics: Adolescent; Adult; Antigens, CD; Child, Preschool; Cytochrome b Group; Eosinophils; Female; Granulocytes; Granulomatous Disease, Chronic; Humans; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidation-Reduction; Oxygen Consumption; Pedigree; Point Mutation; Promoter Regions, Genetic; Rhodamines; Tetradecanoylphorbol Acetate; Tetraspanin 29; Zymosan | 2000 |
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system.
Topics: Animals; Azides; Catalase; Chlorides; Chromium Radioisotopes; Cyanides; Cytotoxicity Tests, Immunologic; Glucosephosphate Dehydrogenase Deficiency; Granulomatous Disease, Chronic; Humans; Hydrogen Peroxide; Iodides; Lymphoma; Male; Mice; Mice, Inbred BALB C; Neutrophils; Opsonin Proteins; Peroxidase; Peroxidases; Phagocytosis; Zymosan | 1975 |
Hydroxyl radical generation by polymorphonuclear leukocytes measured by electron spin resonance spectroscopy.
Topics: Catalase; Electron Spin Resonance Spectroscopy; Free Radicals; Granulomatous Disease, Chronic; Humans; Hydroxides; Mannitol; Neutrophils; Peroxidase; Peroxidases; Phagocytosis; Superoxide Dismutase; Zymosan | 1979 |
Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease.
Topics: Cell-Free System; Child, Preschool; Cytochrome Reductases; Female; Granulocytes; Granulomatous Disease, Chronic; Humans; Leukocytes; Male; Methods; NAD; NADH, NADPH Oxidoreductases; NADP; Opsonin Proteins; Oxidation-Reduction; Oxygen; Phagocyte Bactericidal Dysfunction; Sex Chromosomes; Superoxides; Zymosan | 1975 |
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism.
Topics: Blood; Chemotaxis, Leukocyte; Granulomatous Disease, Chronic; Humans; Neutrophils; Oxygen Consumption; Peptides; Zymosan | 1979 |
Enhancement of human neutrophil bactericidal activity by chemotactic factors.
Topics: Blood Bactericidal Activity; Chemotaxis, Leukocyte; Complement C5; Granulomatous Disease, Chronic; Hexosephosphates; Humans; N-Formylmethionine; Neutrophils; Oligopeptides; Zymosan | 1979 |
Chronic granulomatous disease in an adult male: A proposed X-linked defect.
Topics: Adult; Blood Bactericidal Activity; Chromosomes; Enterococcus faecalis; Female; Granulomatous Disease, Chronic; Hexosephosphates; Humans; Iodides; Leukocytes; Male; Nitroblue Tetrazolium; Oxygen Consumption; Phagocyte Bactericidal Dysfunction; Phagocytosis; Proteus mirabilis; Staphylococcus aureus; Zymosan | 1976 |
Superoxide-forming enzyme from human neutrophils: evidence for a flavin requirement.
Topics: Adenine Nucleotides; Detergents; Flavins; Granulomatous Disease, Chronic; Humans; Neutrophils; Peroxides; Zymosan | 1977 |
Chemiluminescence resulting from an interaction between imipramine and human polymorphonuclear leukocytes.
Topics: Amitriptyline; Animals; Cell-Free System; Child; Drug Synergism; Granulomatous Disease, Chronic; Humans; Imipramine; In Vitro Techniques; Luminescent Measurements; Macrophages; Male; Neutrophils; Pulmonary Alveoli; Rats; Zymosan | 1977 |
[Chronic granulomatous disease: the spectrum of the clinico-laboratory disorders and the therapeutic procedure].
Topics: Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Female; Granulomatous Disease, Chronic; Humans; Immunologic Deficiency Syndromes; Immunotherapy; Infant; Luminescent Measurements; Lymphocyte Subsets; Male; Respiratory Burst; Zymosan | 1991 |
A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123.
Topics: Animals; Granulomatous Disease, Chronic; Humans; Mice; Oxygen; Phagocytes; Rhodamines; Tetradecanoylphorbol Acetate; Xanthenes; Zymosan | 1990 |
Factors important for the measurement of chemiluminescence production by polymorphonuclear leukocytes.
Topics: ABO Blood-Group System; Culture Media; Female; Granulomatous Disease, Chronic; Humans; Immunity, Cellular; Immunologic Techniques; Luminescent Measurements; Male; Neutrophils; Peroxidase; Temperature; Time Factors; Zymosan | 1986 |
Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granulomat
Topics: Amphotericin B; Benzoates; Benzoic Acid; Biological Factors; Catalase; Cytokines; Free Radicals; Granulomatous Disease, Chronic; Humans; Lactoferrin; Male; Monocytes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Opsonin Proteins; Oxygen Consumption; Phagocytosis; Phorbol 12,13-Dibutyrate; Receptors, Fc; Zymosan | 1988 |
Detection of carriers of the autosomal form of chronic granulomatous disease.
Topics: Genetic Carrier Screening; Granulomatous Disease, Chronic; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Oxygen Consumption; Tetradecanoylphorbol Acetate; Zymosan | 1988 |
Purified protein kinase C phosphorylates a 47-kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease.
Topics: Chromosome Aberrations; Chromosome Disorders; Electrophoresis, Polyacrylamide Gel; Granulomatous Disease, Chronic; Humans; Molecular Weight; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxygen Consumption; Phosphorylation; Protein Kinase C; Tetradecanoylphorbol Acetate; Zymosan | 1988 |
Abnormal erythrocyte and lymphocyte chemiluminescence in chronic granulomatous disease: evidence for a generalized membrane defect.
Topics: Adolescent; Child; Child, Preschool; Cytotoxicity, Immunologic; Erythrocyte Membrane; Female; Granulomatous Disease, Chronic; Humans; Infant; Luminescent Measurements; Luminol; Lymphocytes; Male; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Zymosan | 1986 |